Chlamydia trachomatis among women with normal and abnormal cervical smears in Lagos, Nigeria

Maymunah Adeshola Adegbesan-Omilabu, Kehinde Sharafadeen Okunade, Ayotunde Ayodeji Oluwole, Abidoye Gbadegesin, Sunday Aremu Omilabu


Background: Chlamydia trachomatis is one of the most common sexually transmitted disease agents. Cervical intraepithelial neoplasia (CIN) has been independently associated with serological evidence of chlamydial infection. This study therefore was aimed to determine the prevalence of C. trachomatis and the association between Chlamydia trachomatis infection and cervical intra-epithelial lesion.

Methods: It is a cross-sectional case control study carried out at the Lagos University Teaching Hospital (LUTH) with the study participants selected into 2 groups: the case group (women with abnormal smears) and the control group (women with normal Pap smear). Relevant information was obtained using a structured interviewer-administered questionnaire. Endocervical swab sample was collected and analysed by Polymerase Chain Reaction (PCR) test. Data analysis was done using Epi-Info statistical package (version 3.4.3).

Results: The overall prevalence of C. trachomatis was 27.7% with a decreasing trend noted with age (P <0.05). The majority of women with C. trachomatis were in the reproductive age group of 25-45 years. 50% of women with abnormal smears were positive for C. trachomatis, compared to only 16.7% of the controls (X2 = 10.95; P = 0.001). There was no statistically significant association between prevalence of C. trachomatis and cervical cytological types (X2 = 1.892; P = 0.595)

Conclusions: The study revealed an association between Chlamydia trachomatis and precancerous lesions of the cervix. Routine screening and treatment of sexually active adolescents and women in the reproductive age group is recommended as an indirect measure to reducing the incidence of cervical cancer in Nigeria.


Chlamydia trachomatis, Cervical intra-epithelial lesion, PCR, Cervical cancer

Full Text:



Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.

Ferlay J, Bray F, Pisani P, Parkin D. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide, Lyon, France IARC, 2004. Available at: Accessed 12 November 2008.

Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2006;20(2):207-22.

Thomas J, Ojemakinde O, Izebraye I. Current concepts in cervical carcinogenesis and new perspectives in prevention. Arch Ibadan Med. 2002;3(1):36-9.

Castellsague X, Munoz N. Co-factors in human papillomavirus carcinogenesis - role of parity, oral contraceptives and tobacco smoking. J Nat Cancer Inst Monogr. 2003;31:20-8.

Koutsky LA, Holmes, KK, Critchlow CW, Stevens CE, Paavonen J, Beckman AM et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med. 1992;327:1272-8.

Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: a prospective study. Lancet. 1999;354:20-5.

Darougar S, Forsey T, Osoba AO, Dines RJ, Adelusi B, Coker GO. Chlamydia genital infection in Ibadan Nigeria: a sero-epidemiological survey. Br J Vener Dis. 1982;58(6):366-9.

Aladesanmi AF, Mumtaz G, Mabey DC. Prevalence of cervical chlamydial infection in antenatal clinics attendees in Lagos, Nigeria. Genitourin Med. 1988;65(2):130-2.

Amin JD, Zaria LT, El-Nafatty AU, Mai AM. Genital trachomatis infection in women in a Nigerian hospital. Genitourin Med. 1997;73:146-7.

Aboyeji AP, Nwabuisi C. Prevalence of sexually transmitted infection in young pregnant women in Ilorin, Nigeria. J Obstet Gynaecol. 2003;23(6):637-9.

Tukur J, Shittu SO, Abdul AM. A case control study of active genital Chlamydia trachomatis infection among patient with tubal infertility in Northern Nigeria. Trop Doct. 2006;36(1):14-6.

Azenebor AA, Egbafona NO. Association of Chlamydia trachomatis antibodies with genital contact disease in women in Benin City, Nigeria. J Trop Med & Int Health. 2007;2(4):389-92.

Omo-Agboja LO, Okonofua FE, Oremu, SO, Larsen U, Bergstrom S. Association of Chlamydia trachomatis serology with tubal infertility in Nigeria women. J Obstet & Gynaecol Res. 2007;33(5):688-95.

Madeleine MM, Antilla T, Schnertz S, Sakku P, Leinonen M, Joseph J. Risk of cervical cancer associated with Chlamydial trachomatis antibodies by histology, HPV types and HPV co-factors. Int J Cancer. 2007;120(3):650-5.

Silins I, Ryd W, Strand A, Wadell G, Tornberg S, Hansson BG. Chlamydial trachomatis infection and persistence of human papillomavirus. Int J Cancer. 2005;116:110-5.

Norman J. Epidemiology of female genital Chlamydia trachomatis infection. Best Pract Res Clin Obstet Gynaecol. 2002;16(6):775-87.

Fasubaa OB, Onayade AA, Ajenifuja TO. Experience of tubal surgery for infertility at the Obafemi Awolowo teaching hospital, Ile-Ife, Nigeria. Afr J Med Med Sci. 2004;33(4):355-60.

Umeora OU, Mbazor JO, Okpere EE. Tubal factor infectivity in Benin City, Nigeria: Socio-demographic of patients and aetiopathogenic factors. Trop Doct. 2007;37(2):92-4.

Otuonye NM, Olukoya DK, Odunukwe NN, Idigbe EO, Udeaja MN, Bamidele M et al. HIV association with conventional sexually transmitted diseases in Lagos State Nigeria. West Afr J Med. 2002;21(2):153-6.

Oshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutation Res. 1994;305:253-64.

Rosin MP, Anwar WA, Ward AJ. Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res. 1994;54:1929-33.

Parsonnet J. Helicobacter pylori and gastric adenocarcinoma. In: Parsonnet J, eds. Microbes and Malignancy. Infection as a Cause of Human Cancers. 1st ed. New York: Oxford University Press; 1999: 372-408.

Rosin M, Hofseth L. Schistosomiasis, bladder and colon cancer. In: Parsonnet J, eds. Microbes and Malignancy. Infection as a Cause of Human Cancers. 1st ed. New York: Oxford University Press; 1999: 313-345.

Mayer JM, Woods ML, Vavrin Z, Hibbs JB. Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells. Infect Immun. 1993;61:491-7.

Fan B, Lu H, Hu H, Shi L, McClarty G, Nance D et al. Inhibition of apoptosis in Chlamydia-infected cells: blockade of mitochondrial cytochrome C release and caspase activation. J Exp Med. 1998;187: 487-96.

Schlesselman JJ. Sample size requirements in Cohort and case control studies of disease. Am J Epid. 1974;99(6):381-4.

National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical/vaginal cancer diagnoses. J Am Med Assoc. 1989;262:931.

World Health Organization. Sexually transmitted and other reproductive tract infections, 2005. Available at: /publications/rlis.gep/rtisgep.pdf. Accessed 20 November 2007.

World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections. In: WHO, eds. WHO Overview and Estimates. Geneva: WHO; 2001: 1-52.

Wanerheit JN. Chlamydial infection. Sex Trans Dis. 1990;19:61-79.

Keegan H, Ryan F, Malkin A, Grriffin M, Lambkin H. Chlamydia trachomatis detection in cervical preservCyt specimens from an Irish urban female population. Cytopath. 2009;20:111-6.

Reesink-Peters N, Ossewaarde JM, Van Der Zee AG, Quint WG, Burger MP, Adriaanse AH. No association of anti-Chlamydia trachomatis antibodies and severity of cervical neoplasia. Sex Transm Infect. 2001 Apr;77(2):101-2.

Takac I, Gorisek B. Chlamydia trachomatis infection in women with and without CIN. Int J STD AIDS. 1999 May;10:331-3.

Golijow CD, Abba MC, Mouron SA, Laguen RM, Dulout FN, Smiths JS. Chlamydia trachomatis and human papilloma virus infection in cervical disease in Argentine women. Gynaecol Oncol. 2005;96(1):181-6.

Micheline LO, Melania MR, Paulo RES, Lucia CBA, Lucas ACB, Rafael LG. Chlamydia infection in patients with and without cervical intra epithelial lesions tested by real-time PCR versus Direct immunofluorescence. Bras J Infect Dis. 2008;12(4):324-8.

Molano M, Weiderpass E, Passo H, Morre SA, Ronderas M, Franceschi S et al. Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Columbia. Sex Transm Infect. 2003;79:474-8.

Cecil JA, Howell MR, Tawes JJ, Gaydas JC, Mckee Jr KT, Quinn TC et al. Feature of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male army recruits. J Infect Dis. 2001;184:1216-9.